ArticleMolecular and clinical oncology2016

Significant antitumor response of disseminated glioblastoma to bevacizumab resulting in long-term clinical remission in a patient with encephalocraniocutaneous lipomatosis: A case report.

Raita Fukaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.